Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2022-08-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors about the date of a board meeting to consider and approve the interim results for the six months ended June 30, 2022. It does not contain the interim financial report itself, but rather informs about the upcoming meeting where the interim results will be reviewed. The document length is short (1463 characters) and it is clearly an announcement, not the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a board meeting and upcoming financial results, not the Interim Report (IR) itself.
2022-08-01 English
UPDATE ON POSITIVE PROFIT ALERT
Capital/Financing Update Classification · 90% confidence The document is an announcement from Kindstar Globalgene Technology, Inc. providing an update on a positive profit alert for the six months ended June 30, 2022 (1H2022). It references unaudited consolidated management accounts and states that the interim results announcement is expected to be published later. The document is relatively short (3704 characters) and serves as a preliminary profit update rather than a full interim or annual report. It does not contain actual financial statements or detailed financial analysis but rather a summary and cautionary note to investors. This fits the category of a Capital/Financing Update (CAP) or possibly a Regulatory Filing (RNS). However, since it is specifically an update on profit alert and financial performance expectations, it aligns best with Capital/Financing Update (CAP).
2022-08-01 English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors regarding the change of address of the company's principal place of business and the Hong Kong branch share registrar and transfer office. It does not contain financial data, management discussion, voting results, or any report content. The document is short (2046 characters) and serves as a formal notification of administrative changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-28 English
POSITIVE PROFIT ALERT
Regulatory Filings Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement made pursuant to the Listing Rules and Inside Information Provisions. It provides preliminary unaudited financial information for the six months ended June 30, 2022 (1H2022), including expected revenue and profit trends, but explicitly states that the interim results are still being finalized and will be published later. The document is short (4257 characters) and serves as a profit warning or earnings preview rather than a full interim report. It does not contain actual financial statements or detailed financial data, only preliminary management accounts and forward-looking statements. Therefore, it is not an Interim/Quarterly Report (IR) but rather a regulatory announcement about expected financial performance. This fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific report types.
2022-07-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on share capital, issued shares, share options, repurchases, and confirmations related to securities issued by Kindstar Globalgene Technology, Inc. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting share capital changes and share transactions, but it is not a financial report, earnings release, or management discussion. It is also not a simple announcement or a proxy statement. The document fits the category of a regulatory filing reporting share capital movements and confirmations to the exchange, which aligns with the 'Regulatory Filings (RNS)' category as a fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2022-07-06 English
SHARE PURCHASE PURSUANT TO THE POST-IPO RSU SCHEME
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the company's share purchase pursuant to the Post-IPO RSU Scheme. It details the number of shares purchased by the RSU Trustee, the amount spent, and the purpose of the shares as awards for selected participants. There is no financial statement, no detailed financial analysis, and the document is relatively short (2631 characters). It is not a full report but an announcement of a share purchase related to a share scheme. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares or share repurchase/issuance activities. Therefore, the appropriate classification is POS with high confidence.
2022-07-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.